University of Texas at Austin — Austin, Texas

Public research footprint of University of Texas at Austin, compiled from the ClinicalTrials.gov public registry.

264

Registered studies

Active

Recruiting now

136

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm · Unresectable Malignant Solid Neoplasm · Attention Deficit Hyperactivity Disorder

Recently updated registry entries

NCT04847453 — Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or… (Active Not Recruiting)
NCT03842228 — Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736… (Active Not Recruiting)
NCT07196748 — A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Texas at Austin?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.